Quote:
Originally Posted by drducat
So...What do you think of this study from Japan. Granted it covers the vaccine... however...would this apply also to the long term issues with the virus with sleen, liver, etc retaining the spike protein? https://files.catbox.moe/0vwcmj.pdf |
No. It's a description of the pharmacokinetics of the vaccine (AVD, metabolism, excretion, tissue penetration, etc.). It does not address anything clinical at all. Looks like it might be information that Pfizer pharmacists and molecular geneticists put out as part of their bid to get full FDA approval (although I doubt the radioimmunoflourescence study in 6 rats will pass the committee